The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Sphingosine 1-Phosphate Receptor Signaling
Abstract
The sphingosine 1-phosphate (S1P) receptor signaling system is a productive model system. A hydrophobic zwitterionic lysophospholipid ligand with difficult physical properties interacts with five high-affinity G protein–coupled receptors to generate multiple downstream signals. These signals modulate homeostasis and pathology on a steep agonist concentration-response curve. Ligand presence is essential for vascular development and endothelial integrity, while acute increases in ligand concentrations result in cardiac death. Understanding this integrated biochemical system has exemplified the impact of both genetics and chemistry. Developing specific tools with defined biochemical properties for the reversible modulation of signals in real time has been essential to complement insights gained from genetic approaches that may be irreversible and compensated. Despite its knife-edge between life and death, this system, based in part on receptor subtype-selectivity and in part on differential attenuation of deleterious signals, now appears to be on the cusp of meaningful therapy for multiple sclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early studies of primary bile acids have been shown to exert direct negative myocardial chronotropic effects in a dose-dependent fashion132,133.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [132]
In the citing paper
“Though at lower concentrations relative to primary bile acids even in cholestatic states, secondary bile acids can also exert similar effects.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [132]
Citations
Cites
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,411
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Kühn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,280
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Sphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,115
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
MANDALA, S. M., Hajdu, R., Bergstrom, J. D., Quackenbush, E. J., Xie, J., Milligan, J. A., Thornton, R. A., Shei, G.-J., Card, D., Keohane, C.-A., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,691
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E. E., Baumruker, T., HIESTAND, P. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,512
GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,335
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,165
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J. P., Comi, G., Montalbán, X., O'Connor, P. W., Polman, C. H., Haas, T., Korn, A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,058
Research works printed but not linked: 6
- Clair T, 2003, Cancer Res., 63, 5446
- 10.1042/0264-6021:3520809 · DOI
- Chiba K, 2006, Cell Mol. Immunol., 3, 11
- Suzuki S, 1998, Transplant. Int., 11, 95
- Suzuki S, 1996, Transplant. Proc., 28, 2049
- Merrill AH, 2007, Naunyn-Schmiedebergs Arch. Pharmacol., 374, 321
Cited by
Sorted by citations
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Dietary metabolism, the gut microbiome, and heart failure
Tang, W. H. W., Li, D. Y., & Hazen, S. L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0108-7 · Cited by 789
Teijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., Martinborough, E., Peach, R., Oldstone, M. B. A., & Rosen, H. (2011) · Cell · doi:10.1016/j.cell.2011.08.015 · Cited by 688
Self-citationSequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
Chongsathidkiet, P., Jackson, C., Koyama, S., Loebel, F., Cui, X., Farber, S. H., Woroniecka, K. I., Elsamadicy, A. A., Dechant, C. A., Kemeny, H. R., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0135-2 · Cited by 675
Crystal Structure of a Lipid G Protein–Coupled Receptor
Hanson, M. A., Roth, C., Jo, E., Griffith, M. T., Scott, F. L., Reinhart, G. J., Desale, H., Clemons, B., Cahalan, S. M., Schuerer, S. C., et al. (2012) · Science · doi:10.1126/science.1215904 · Cited by 662
Self-citationRegulation of Endothelial Permeability via Paracellular and Transcellular Transport Pathways
Komarova, Y. A., & Malik, A. B. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135833 · Cited by 640
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., Wolf, D. C., D’Haens, G., Vermeire, S., Hanauer, S. B., Ghosh, S. K., Smith, H., Cravets, M. W., Frohna, P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513248 · Cited by 451
An update on sphingosine-1-phosphate and other sphingolipid mediators
Fyrst, H., & Saba, J. D. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.392 · Cited by 350
Kajimoto, T., Okada, T., Miya, S., Zhang, L., & Nakamura, S. (2013) · Nature Communications · doi:10.1038/ncomms3712 · Cited by 332
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions
McGinley, M., & Cohen, J. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00244-0 · Cited by 320
Regulation of sphingosine kinase and sphingolipid signaling
Pitson, S. M. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.08.001 · Cited by 314
Membranes in Balance: Mechanisms of Sphingolipid Homeostasis
Breslow, D. K., & Weissman, J. S. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.005 · Cited by 303
Comı, G., Kappos, L., Selmaj, K. W., Bar‐Or, A., Arnold, D. L., Steinman, L., Hartung, H., Montalbán, X., Havrdová, E., Cree, B., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30239-x · Cited by 297
Wang, X., He, Q., Zhou, C., Xu, Y., Liu, D., Fujiwara, N., Kubota, N., Click, A., Henderson, P., Vancil, J., et al. (2023) · Immunity · doi:10.1016/j.immuni.2022.11.013 · Cited by 262
Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets
Vu, M. T., Ishizu, A.-N., Foo, J. C., Toh, X. R., Zhang, F., Whee, D. M., Torta, F. T., Cazenave‐Gassiot, A., Matsumura, T., Kim, S., et al. (2017) · Nature · doi:10.1038/nature24053 · Cited by 241
Sphingosine-1-Phosphate and Its Receptors: Structure, Signaling, and Influence
Rosen, H., Stevens, R. C., Hanson, M. A., Roberts, E., & Oldstone, M. B. A. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062411-130916 · Cited by 231
Self-citationIntestinal absorption of bile acids in health and disease
Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K., & Alrefai, W. A. (2019) · Comprehensive physiology · doi:10.1002/cphy.c190007 · Cited by 215
Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells
Hisano, Y., Kobayashi, N., Yamaguchi, A., & Nishi, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038941 · Cited by 219
Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency
Lovric, S., Gonçalves, S., Gee, H. Y., Oskouian, B., Srinivas, H., Choi, W., Shril, S., Ashraf, S., Tan, W., Rao, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89626 · Cited by 209
Interaction of G protein coupled receptors and cholesterol
Gimpl, G. (2016) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2016.04.006 · Cited by 202
Soleimani, R., Heytens, E., & Oktay, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019475 · Cited by 197
Review of Eukaryote Cellular Membrane Lipid Composition, with Special Attention to the Fatty Acids
Ali, O., & Szabó, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115693 · Cited by 223
Sphingosine-1-phosphate and immune regulation: trafficking and beyond
Chi, H. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.002 · Cited by 184
Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function
Serra, M., & Saba, J. D. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.024 · Cited by 183
Cohen, J. A., Arnold, D. L., Comi, G., Bar‐Or, A., Gujrathi, S., Hartung, J. P., Cravets, M., Olson, A. D., Frohna, P., & Selmaj, K. W. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00018-1 · Cited by 177
Park, S.-J., Kim, J. M., Kim, J., Hur, J., Park, S., Kim, K. H., Shin, H., & Chwae, Y. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811432115 · Cited by 182
New Therapeutics for Ulcerative Colitis
Hirten, R. P., & Sands, B. E. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-052919-120048 · Cited by 177
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
Pan, S., Gray, N. S., Gao, W., Mi, Y., Fan, Y., Wang, X., Tuntland, T., Che, J., Lefebvre, S., Chen, Y. A., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300396r · Cited by 173
Roles, regulation and inhibitors of sphingosine kinase 2
Neubauer, H. A., & Pitson, S. M. (2013) · FEBS Journal · doi:10.1111/febs.12314 · Cited by 171
Sphingosine‐1‐phosphate receptor 1 signalling in T cells: trafficking and beyond
Garris, C., Blaho, V. A., Hla, T., & Han, M. H. (2014) · Immunology · doi:10.1111/imm.12272 · Cited by 166
Next generation of small molecules in inflammatory bowel disease
Olivera, P., Danese, S., & Peyrin-Biroulet, L. (2017) · Gut · doi:10.1136/gutjnl-2016-312912 · Cited by 154
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis
Karlsson, G., Francis, G., Koren, G., Heining, P., Zhang, X., Cohen, J. A., Kappos, L., & Collins, W. (2014) · Neurology · doi:10.1212/wnl.0000000000000137 · Cited by 157
Diaryl Ether: A Privileged Scaffold for Drug and Agrochemical Discovery
Chen, T., Xiong, H., Yang, J., Zhu, X., Qu, R., & Yang, G. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c03369 · Cited by 158
Murakami, A., Takasugi, H., Ohnuma, S., Koide, Y., Sakurai, A., Takeda, S., Hasegawa, T., Sasamori, J., Konno, T., Hayashi, K., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061481 · Cited by 152
Feng, H., Stachura, D. L., White, R. M., Gutiérrez, A., Zhang, L., Sanda, T., Jette, C. A., Testa, J. R., Neuberg, D. S., Langenau, D. M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.009 · Cited by 150
Lysophospholipid Mediators in Health and Disease
Kano, K., Aoki, J., & Hla, T. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-050420-025929 · Cited by 161
Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism
Kwong, E. K., Li, Y., Hylemon, P. B., & Zhou, H. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.12.009 · Cited by 152
Fingolimod modulates microglial activation to augment markers of remyelination
Jackson, S. J., Giovannoni, G., & Baker, D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-76 · Cited by 145
Ceccom, J., Loukh, N., Lauwers‐Cancès, V., Touriol, C., Nicaise, Y., Gentil, C., Uro‐Coste, E., Pitson, S. M., Maurage, C., Duyckaerts, C. J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-12 · Cited by 140
Abuhusain, H. J., Matin, A., Qiao, Q., Shen, H. M., Kain, N., Day, B. W., Stringer, B. W., Daniels, B. J., Laaksonen, M. A., Teo, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.494740 · Cited by 132
G protein-coupled receptors as promising cancer targets
Liu, Y., An, S., Ward, R. J., Yang, Y., Guo, X., Li, W., & Xu, T. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.031 · Cited by 134
A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD
Chudy‐Onwugaje, K., Christian, K. E., Farraye, F. A., & Cross, R. K. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy327 · Cited by 131
van Doorn, R., Nijland, P. G., Dekker, N., Witte, M. E., Pinheiro, M. A. L., Hof, B. V. H., Kooij, G., Reijerkerk, A., Dijkstra, C. D., van der Valk, P., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1014-4 · Cited by 125
Mehling, M., Johnson, T., Antel, J. P., Kappos, L., & Bar‐Or, A. (2011) · Neurology · doi:10.1212/wnl.0b013e31820db341 · Cited by 128
Kumaraswamy, S. B., Linder, A., Åkesson, P., & Dahlbäck, B. (2012) · Critical Care · doi:10.1186/cc11305 · Cited by 125
Cheng, Y., Feng, Y., Jansson, L., Sato, Y., Deguchi, M., Kawamura, K., & Hsueh, A. J. W. (2015) · The FASEB Journal · doi:10.1096/fj.14-267856 · Cited by 123
Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus
Kanno, T., Nishizaki, T., Proia, R. L., Kajimoto, T., Jahangeer, S. M., Okada, T., & Nakamura, S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.021 · Cited by 111
Piali, L., Froidevaux, S., Hess, P., Nayler, O., Bolli, M. H., Schlosser, E., Kohl, C., Steiner, B., & Clozel, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.176487 · Cited by 110
Zeng, Y., Yao, X., Chen, L., Yan, Z., Liu, J., Zhang, Y., Feng, T., Wu, J., & Liu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.11450 · Cited by 108
Endothelial Functions of Sphingosine-1-phosphate
Lucke, S., & Levkau, B. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315109 · Cited by 104
Mamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 100
The Role of Sphingosine-1-Phosphate Transporter Spns2 in Immune System Function
Nijnik, A., Clare, S., Hale, C., Chen, J., Raisen, C. L., Mottram, L., Lucas, M., Estabel, J., Ryder, E., Adissu, H. A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200282 · Cited by 100
Rutherford, C., Childs, S., Ohotski, J., McGlynn, L. M., Riddick, M., Macfarlane, S. R., Tasker, D., Pyne, S., Pyne, N. J., Edwards, J., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.455 · Cited by 100
Kim, E.-S., Kim, J.-S., Kim, S. G., Hwang, S., Lee, C. H., & Moon, A. (2011) · Journal of Cell Science · doi:10.1242/jcs.076794 · Cited by 93
Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin
Nußbaum, C., Bannenberg, S., Keul, P., Gräler, M. H., Gonçalves-de-Albuquerque, C. F., Korhonen, H., Lipinski, K. V. W., Heusch, G., Neto, H. C. D. C. F., Rohwedder, I., et al. (2015) · Nature Communications · doi:10.1038/ncomms7416 · Cited by 98
Inflammatory and microenvironmental factors involved in breast cancer progression
Ham, M., & Moon, A. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0271-7 · Cited by 95
Zanoni, P., Velagapudi, S., Yalçınkaya, M., Rohrer, L., & von Eckardstein, A. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.881 · Cited by 97
Cantrell, J. E. L., Morris, A. J., Sunkara, M., Popa, G. J., Larson, K., & Özcan, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.268185 · Cited by 94
Awojoodu, A. O., Keegan, P. M., Lane, A. R., Zhang, Y., Lynch, K. R., Platt, M. O., & Botchwey, E. A. (2014) · Blood · doi:10.1182/blood-2014-01-543652 · Cited by 93
Oldstone, M. B. A., & Rosen, H. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-05879-5_6 · Cited by 85
Self-citationSphingosine-1-phosphate: A Janus-faced mediator of fibrotic diseases
Schwalm, S. A., Pfeilschifter, J. M., & Huwiler, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.022 · Cited by 84
Intravasation as a Key Step in Cancer Metastasis
Zavyalova, M. V., Denisov, E. V., Таширева, Л. А., Savelieva, O. E., Кайгородова, Е. В., Krakhmal, N. V., & Михайлович, П. В. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919070071 · Cited by 86
G protein‐coupled receptors: the inside story
Jalink, K., & Moolenaar, W. H. (2009) · BioEssays · doi:10.1002/bies.200900153 · Cited by 79
Brizuela, L., Martin, C., Jeannot, P., Ader, I., Gstalder, C., Andrieu, G. P., Bocquet, M., Laffosse, J., Gomez‐Brouchet, A., Malavaud, B. A., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.04.001 · Cited by 81
Rokitta, S. D., John, U., & Rost, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052212 · Cited by 75
Kennedy, A. J., Mathews, T. P., Kharel, Y., Field, S. D., Moyer, M. L., East, J. E., Houck, J. D., Lynch, K. R., & Macdonald, T. L. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2001053 · Cited by 74
Role of the microbiota–gut–heart axis between bile acids and cardiovascular disease
Zhang, Z., Lv, T., Wang, X., Wu, M., Zhang, R., Yang, X., Fu, Y., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116567 · Cited by 79
G-Protein-Coupled Receptors in Adult Neurogenesis
Doze, V. A., & Perez, D. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004762 · Cited by 75
Benzyl butyl phthalate promotes breast cancer stem cell expansion via SPHK1/S1P/S1PR3 signaling
Wang, Y., Tsai, C., Chuang, H.-L., Chang, Y., Chen, H., Lee, J.-N., & Tsai, E. (2016) · Oncotarget · doi:10.18632/oncotarget.9007 · Cited by 74
Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions
Mehling, M., Kappos, L., & Derfuss, T. J. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0216-9 · Cited by 74
Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain
Salvemini, D., Doyle, T. M., Kress, M., & Nicol, G. D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.12.001 · Cited by 71
Chan, J., Hu, Z., & Sieburth, D. (2012) · Genes & Development · doi:10.1101/gad.188003.112 · Cited by 72
Zhang, T., Yan, T., Du, J., Wang, S., & Yang, H. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.12.021 · Cited by 72
New developments in C5a receptor signaling
Ward, P. A., & Sarma, J. V. (2012) · Cell Health and Cytoskeleton · doi:10.2147/chc.s27233 · Cited by 71
Mao‐Draayer, Y., Sarazin, J., Fox, D. A., & Schiopu, E. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.11.008 · Cited by 72
Kajimoto, T., Mohamed, N. N. I., Badawy, S. M. M., Matovelo, S. A., Hirase, M., Nakamura, S., Yoshida, D., Okada, T., Ijuin, T., & Nakamura, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.808733 · Cited by 74
Lyase to live by: Sphingosine phosphate lyase as a therapeutic target
Kumar, A., & Saba, J. D. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903039722 · Cited by 70
Rathinasamy, A., Czeloth, N., Pabst, O., Förster, R., & Bernhardt, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000568 · Cited by 73
Bouquerel, P., Gstalder, C., Müller, D., Laurent, J., Brizuela, L., Sabbadini, R. A., Malavaud, B. A., Pyronnet, S., Martineau, Y., Ader, I., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.13 · Cited by 73
S1PR3 Signaling Drives Bacterial Killing and Is Required for Survival in Bacterial Sepsis
Hou, J., Chen, Q., Wu, X., Zhao, D., Reuveni, H., Licht, T., Xu, M., Hu, H., Hoeft, A., Ben‐Sasson, S. A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0241oc · Cited by 70
Pharmacological relevance and potential of sphingosine 1‐phosphate in the vascular system
Schuchardt, M., Tölle, M., Prüfer, J., & van der Giet, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01260.x · Cited by 69
A sphingosine 1-phosphate receptor 2 selective allosteric agonist
Satsu, H., Schaeffer, M., Guerrero, M. A., Saldana, A., Eberhart, C., Hodder, P., Cayanan, C. S., Schürer, S. C., Bhhatarai, B., Roberts, E., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.06.012 · Cited by 69
Self-citationThe role of sphingosine-1-phosphate in endothelial barrier function
Wilkerson, B. A., & Argraves, K. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.06.012 · Cited by 71
Fernández‐Pisonero, I., Dueñas, A. I., Barreiro, O., Montero, O., Sánchez‐Madrid, F., & García‐Rodríguez, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201309 · Cited by 67
Bile acids and cardiovascular function in cirrhosis
Voiosu, A. M., Wiese, S. S., Voiosu, T. A., Bendtsen, F., & Møller, S. (2017) · Liver International · doi:10.1111/liv.13394 · Cited by 70
Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao, H., Zhu, Y., Hu, G., Zhang, Q., & Zheng, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106586 · Cited by 64
Novel Selective Allosteric and Bitopic Ligands for the S1P3 Receptor
Jo, E., Bhhatarai, B., Repetto, E., Guerrero, M. A., Riley, S., Brown, S. J., Kohno, Y., Roberts, E., Schürer, S. C., & Rosen, H. (2012) · ACS Chemical Biology · doi:10.1021/cb300392z · Cited by 62
Self-citationSphingosine 1-Phosphate Distribution in Human Plasma: Associations with Lipid Profiles
Hammad, S. M., Gadban, M. M. A., Semler, A. J., & Klein, R. L. (2012) · Journal of Lipids · doi:10.1155/2012/180705 · Cited by 62
Regulation of Stem Cell Pluripotency and Neural Differentiation by Lysophospholipids
Pitson, S. M., & Pébay, A. (2009) · Neurosignals · doi:10.1159/000231891 · Cited by 62
Potì, F., Gualtieri, F., Sacchi, S., Weißen-Plenz, G., Varga, G., Brodde, M. F., Weber, C., Simoni, M., & Nofer, J. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301347 · Cited by 65
Li, Q., Chen, B., Zeng, C., Fan, A., Yuan, Y., Guo, X., Huang, X., & Huang, Q. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.082149 · Cited by 62
Sphingosine pathway deregulation in endometriotic tissues
Santulli, P., Marcellin, L., Noël, J., Borghese, B., Fayt, I., Vaiman, D., Chapron, C., & Méhats, C. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.12.051 · Cited by 65
Role of FAK in S1P-regulated endothelial permeability
Belvitch, P. G., & Dudek, S. M. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.08.012 · Cited by 63
Siow, D. L., & Wattenberg, B. W. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.580097 · Cited by 63
Sphingosine 1-Phosphate Mediates Hyperalgesia via a Neutrophil-Dependent Mechanism
Finley, A., Chen, Z., Esposito, E., Cuzzocrea, S., Sabbadini, R. A., & Salvemini, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055255 · Cited by 61
Waes, J. G., Rainey, M. A., Maddox, J. R., Voss, K. A., Sachs, A. J., Gardner, N. M., Wilberding, J., & Riley, R. T. (2012) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23074 · Cited by 63
Walsh, K. B., Teijaro, J. R., Brock, L. G., Fremgen, D. M., Collins, P. L., Rosen, H., & Oldstone, M. B. A. (2014) · Journal of Virology · doi:10.1128/jvi.00464-14 · Cited by 59
Self-citationSphingosine kinase 1 in viral infections
Carr, J. M., Mahalingam, S., Bonder, C. S., & Pitson, S. M. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.1718 · Cited by 59
Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy
Nguyen-Tran, D.-H., Hait, N. C., Sperber, H., Qi, J., Fischer, K., Ieronimakis, N., Pantoja, M., Hays, A., Allegood, J., Reyes, M., et al. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.013631 · Cited by 58
Dumitrescu, L., Papathanasiou, A. I., Coclitu, C., Garjani, A., Evangelou, N., Constantinescu, C. S., Popescu, B. O., & Tănăsescu, R. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2178898 · Cited by 60
Metadata
- Authors
- Rosen, H., Gonzalez-Cabrera, P. J., Sanna, M. G., & Brown, S.
- Affiliations
- Scripps Research Institute (US)
- Departments of Chemical Physiology and Immunology and The Scripps Research Institute Molecular Screening Center, The Scripps Research Institute, La Jolla, California 92037;
- Venue
- Annual Review of Biochemistry
- Publisher
- Annual Reviews
- Published
- 2009-06-01
- Volume
- 78
- Issue
- 1
- Pages
- 743-768
- ISSN
- 0066-4154 (ISSN-L)
- 1545-4509
- OpenAlex
- W2127032203
- Cited by
- 404
- References
- 151
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 8 · 2023: 10 · 2022: 12 · 2021: 19 · 2020: 17 · 2019: 18 · 2018: 29 · 2017: 27 · 2016: 28 · 2015: 21 · 2014: 27 · 2013: 48 · 2012: 50
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, receptor signaling, vascular development, endothelial integrity, cardiovascular mortality, signal attenuation, receptor subtype selectivity, multiple sclerosis treatment
- MeSH terms
- Animals, Cardiovascular System, Humans, Lymphoid Tissue, Multiple Sclerosis, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review